A global health care company says that it will begin making state of the art cancer fighting medicines in our area. It’s a move that Pennsylvania Gov. Josh Shapiro says won’t just save lives but will also create jobs.

Johnson & Johnson JNJ reported 6.0% sales growth and 8.1% diluted adjusted earnings per share growth in 2025, with 2026 growth guidance of 6.7% for sales and 6.9% for diluted adjusted EPS at the midpoint. Why it matters: The biopharma industry (including J ...

Feb 19 (Reuters) - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning to separate, with big buyout firms already circling, Bloomberg News reported on Thursday,

Bloomberg reports that Johnson & Johnson (NYSE: JNJ) aims to sell its DePuy Synthes Orthopaedics business for more than $20 billion.

Verizon (NYSE: VZ) and Johnson & Johnson (NYSE: JNJ) both rewarded shareholders with dividend increases this quarter, but their paths to sustaining those payouts look very different. Verizon raised its quarterly dividend to $0.

The U.S. Food and Drug Administration (FDA) on Tuesday approved a new, simplified monthly dosing schedule for Johnson & Johnson’s JNJ Rybrevant Faspro (amivantamab and hyaluronidase-lpuj). When administered in combination with oral Lazcluze (lazertinib) for the first-line treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer (NSCLC),